Histogenics Corp (NASDAQ: HSGX) shares were down 73% of their market value at time of publishing following the release data of its Phase 3 clinical trial of NeoCart that did not meet the primary endpoint of a statistically significant improvement in pain and function in a dual threshold responder analysis one year after treatment as […]
On June 26, 2018 Quantum Corp. (QTM) announced that its Board of Directors has appointed Jamie Lerner as Chief Executive Officer and President effective July 1, 2018. Lerner will also be appointed to Quantum’s Board of Directors. Lerner, a seasoned executive with experience developing innovative technology portfolios and leading high-growth organizations, will oversee the day-to-day […]
Congratulations to PSH email subscribers who had follow our TLED alert on November 1st – TLED shares jumped from $.11 to $0.17 just in 5 trading sessions. Read email to subscribers below and be ready for the next winning alert! If you’ve been looking for a way to play the explosion in cannabis sales in […]
A few facts… Excerpts from the Company’s Financial Results for the Third Quarter Ended September 30, 2016: Total operating expenses for the quarter ended September 30, 2016 were $1,801,000, a decrease of 48.5% compared to $3,500,000 for the same period in 2015. This decrease was primarily due to a reduction of compensation related expenses, consultant […]
SIEN: see you at chart reversal News: SANTA BARBARA, Calif., Oct. 28, 2015 (GLOBE NEWSWIRE) — Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company, announced today that the Company will host an investor and analyst update conference call on Wednesday October 28, 2015 at 4:15 p.m. ET/1:15 p.m. PT. The dial-in numbers are (844) 464-3933 for […]
Sanuwave (SNWV) stated that enrollment for the last part of their phase III study of ‘dermaPACE’ is set to begin before the end of Q2 – which is less than 30 days away. This is a huge catalyst for the company’s shares, which have traded completely under the radar thus far. dermaPACE is a device […]
ARCA Biopharma (ABIO) has been alerted as day-trading investment opportunity in real-time to our Twitter & Facebook followers at an around $.50/share. ABIO stock closed at $.68/share for the solid 36% in day-trading gains. Yesterday ABIO announced an update on a proposed, genetically-targeted clinical trial in atrial fibrillation (“AF”) of the Company’s lead developmental drug, Gencaro […]
Implant Sciences develops and manufactures explosive trace detection sensors and systems that are capable of detecting minute amounts of a wide variety of military, commercial, and homemade explosives. IMSC’s patented technologies provide unique screening capabilities to extend and improve counter-terrorist and homeland security efforts. Read our due diligence report from the last year here. Yesterday, […]
Amicus Therapeutics (FOLD) has been profiled as a bounce play from December 31th, 2012. Since then FOLD shares gained over 50% (as of now) and have continued their march to the new highs. Today Amicus Therapeutics announced positive preliminary results from all 4 dose cohorts in a Phase 2 study (Study 010) to evaluate the […]
Magnum Hunter Resources Corporation (NYSE: MHR) today announced production results from its two new Eagle Ford Shale wells that have been on production since December 22, 2012. Mr. Gary C. Evans, Chairman and Chief Executive Officer of Magnum Hunter Resources Corporation, noted: These two new Eagle Ford wells are by far our best producers since […]
